Mitchell Cheung

Mitchell Cheung

UNVERIFIED PROFILE

Are you Mitchell Cheung?   Register this Author

Register author
Mitchell Cheung

Mitchell Cheung

Publications by authors named "Mitchell Cheung"

Are you Mitchell Cheung?   Register this Author

25Publications

623Reads

17Profile Views

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

J Natl Cancer Inst 2018 12;110(12):1328-1341

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292796PMC
December 2018

, a tumor suppressor gene driving malignant mesothelioma.

Transl Lung Cancer Res 2017 Jun;6(3):270-278

Cancer Biology Program Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.05.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504107PMC
June 2017

Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction.

Cancer Lett 2015 Dec 26;369(2):261-5. Epub 2015 Sep 26.

Cancer Biology Program and Genomics Facility, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2015.09.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634709PMC
December 2015

Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.

Cancer Genet 2014 Mar 15;207(3):98-102. Epub 2014 Feb 15.

Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA, USA; Clinical Cytogenomics Laboratory, Fox Chase Cancer Center, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergen.2014.02.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010307PMC
March 2014

NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.

Mol Cancer Ther 2013 Aug 8;12(8):1568-78. Epub 2013 May 8.

Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-1010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746800PMC
August 2013

Diverse mechanisms of AKT pathway activation in human malignancy.

Curr Cancer Drug Targets 2013 Mar;13(3):234-44

Cancer Biology Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111-2497, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678724PMC
http://dx.doi.org/10.2174/1568009611313030002DOI Listing
March 2013

Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling.

Cancer Res 2010 Nov 2;70(22):9197-206. Epub 2010 Nov 2.

Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1568DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018149PMC
November 2010

Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent.

BMC Cancer 2010 Feb 5;10:34. Epub 2010 Feb 5.

Cancer Genetics & Signaling Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-10-34DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829496PMC
February 2010

Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

Cancer Res 2008 May;68(9):3429-39

Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-5867DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2603082PMC
May 2008

Deregulated Akt3 activity promotes development of malignant melanoma.

Cancer Res 2004 Oct;64(19):7002-10

Department of Pharmacology, The Pennsylvania State College of Medicine, Hershey, Pennsylvania 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-1399DOI Listing
October 2004

Loss of PTEN promotes tumor development in malignant melanoma.

Cancer Res 2003 Jun;63(11):2881-90

Department of Pharmacology, The Pennsylvania State College of Medicine, Hershey, Pennsylvania 17033, USA.

View Article

Download full-text PDF

Source
June 2003